日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan

在非临床试验环境下，贝达喹啉、普瑞托马尼和利奈唑胺（BPaL）联合方案治疗利福平耐药结核病的有效性和安全性——一项在白俄罗斯和乌兹别克斯坦开展的前瞻性队列研究

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciaf035
Sinha, Animesh; Klebe, Roland; Rekart, Michael L; Alvarez, Jose Luis; Skrahina, Alena; Yatskevich, Natalia; Solodovnikova, Varvara; Viatushka, Dzmitry; Parpieva, Nargiza; Safaev, Khasan; Liverko, Irina; Tigay, Zinaida; Moe, Soe; Khristusev, Aleksandr; Allamuratova, Sholpan; Mirzabaev, Sanjar; Achilov, Muzaffar; Samieva, Nazgul; Lachenal, Nathalie; Merle, Corinne Simone; Sall, Fatimata Bintou; Restrepo, Camilo Gomez; Tan, Cecilio; Sitali, Norman; Saunders, Matthew J
发表日期：2025
文献求助 收藏

Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL

结核病实践中耐多药结核病患者的妊娠结局

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciad767
Crocker-Buque, Tim; Lachenal, Nathalie; Narasimooloo, Cindy; Abdrasuliev, Tleubergen; Parpieva, Nargiza; Tigay, Zinaida; Liverko, Irina; Usmanova, Ruzilya; Butabekov, Ilhomjon; Moodliar, Ronelle; Mbenga, Mansa; Rasool, Mohammad; Nyang'wa, Bern-Thomas; Berry, Catherine
发表日期：2024
文献求助 收藏

How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial

对于利福平耐药结核病，我们还需要多担心QTc间期延长？TB-PRACTECAL临床试验的心电图结果

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00536-24
Motta, Ilaria; Cusinato, Martina; Ludman, Andrew J; Lachenal, Nathalie; Dodd, Matthew; Soe, Moe; Abdrasuliev, Tleubergen; Usmanova, Ruzilya; Butabekov, Ilhomjon; Nikolaevna, Tigay Zinaida; Liverko, Irina; Parpieva, Nargiza; Moodliar, Ronelle; Solodovnikova, Varvara; Kazounis, Emil; Nyang'wa, Bern-Thomas; Fielding, Katherine L; Berry, Catherine
TEC
发表日期：2024
文献求助 收藏

Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort

耐多药/利福平结核病试验队列中丙型肝炎的患病率、治疗和预后

期刊:PLOS Global Public Health
影响因子:2.5
doi:10.1371/journal.pgph.0003057
Jansen van Vuuren, Jocelyn; Crocker-Buque, Tim; Berry, Catherine; Viatushka, Dzmitry; Usmanova, Ruzilya; Nyang'wa, Bern-Thomas; Parpieva, Nargiza; Liverko, Irina; Solodovnikova, Varvara; Sinha, Animesh
肝炎
发表日期：2024
文献求助 收藏

Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013-2018

2013-2018年乌兹别克斯坦耐药结核病患者的趋势、特征和治疗结果

期刊:International Journal of Environmental Research and Public Health
影响因子:
doi:10.3390/ijerph18094663
Safaev, Khasan; Parpieva, Nargiza; Liverko, Irina; Yuldashev, Sharofiddin; Dumchev, Kostyantyn; Gadoev, Jamshid; Korotych, Oleksandr; Harries, Anthony D
发表日期：2021
文献求助 收藏

Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?

乌兹别克斯坦多重耐药结核病治疗依从性：实践是否符合政策？

期刊:International Journal of Environmental Research and Public Health
影响因子:
doi:10.3390/ijerph18084071
Usmanova, Ruzilya; Parpieva, Nargiza; Davtyan, Hayk; Denisiuk, Olga; Gadoev, Jamshid; Alaverdyan, Sevak; Dumchev, Kostyantyn; Liverko, Irina; Abdusamatova, Barno
发表日期：2021
文献求助 收藏